Where Do We Stand with Closed-Loop Systems and Their Challenges

Melanie Jackson; Jessica R. Castle

doi:10.1089/dia.2019.0469

Where Do We Stand with Closed-Loop Systems and Their Challenges

Melanie Jackson, Jessica R. Castle

Endocrinology

Research output: Contribution to journal › Review article › peer-review

4 Scopus citations

Abstract

Treatments for type 1 diabetes have advanced significantly over recent years. There are now multiple hybrid closed-loop systems commercially available and additional systems are in development. Challenges remain, however. This review outlines the recent advances in closed-loop systems and outlines the remaining challenges, including post-prandial hyperglycemia and exercise-related dysglycemia.

Original language	English (US)
Pages (from-to)	485-491
Number of pages	7
Journal	Diabetes Technology and Therapeutics
Volume	22
Issue number	7
DOIs	https://doi.org/10.1089/dia.2019.0469
State	Published - Jul 2020

Keywords

Artificial pancreas
Closed-loop
Continuous glucose monitor

ASJC Scopus subject areas

Endocrinology, Diabetes and Metabolism
Endocrinology
Medical Laboratory Technology

Access to Document

10.1089/dia.2019.0469

Cite this

@article{7487ad10b1054becb7bf21f99e2d273f,

title = "Where Do We Stand with Closed-Loop Systems and Their Challenges",

abstract = "Treatments for type 1 diabetes have advanced significantly over recent years. There are now multiple hybrid closed-loop systems commercially available and additional systems are in development. Challenges remain, however. This review outlines the recent advances in closed-loop systems and outlines the remaining challenges, including post-prandial hyperglycemia and exercise-related dysglycemia. ",

keywords = "Artificial pancreas, Closed-loop, Continuous glucose monitor",

author = "Melanie Jackson and Castle, {Jessica R.}",

year = "2020",

month = jul,

doi = "10.1089/dia.2019.0469",

language = "English (US)",

volume = "22",

pages = "485--491",

journal = "Diabetes Technology and Therapeutics",

issn = "1520-9156",

publisher = "Mary Ann Liebert Inc.",

number = "7",

}

TY - JOUR

T1 - Where Do We Stand with Closed-Loop Systems and Their Challenges

AU - Jackson, Melanie

AU - Castle, Jessica R.

PY - 2020/7

Y1 - 2020/7

N2 - Treatments for type 1 diabetes have advanced significantly over recent years. There are now multiple hybrid closed-loop systems commercially available and additional systems are in development. Challenges remain, however. This review outlines the recent advances in closed-loop systems and outlines the remaining challenges, including post-prandial hyperglycemia and exercise-related dysglycemia.

AB - Treatments for type 1 diabetes have advanced significantly over recent years. There are now multiple hybrid closed-loop systems commercially available and additional systems are in development. Challenges remain, however. This review outlines the recent advances in closed-loop systems and outlines the remaining challenges, including post-prandial hyperglycemia and exercise-related dysglycemia.

KW - Artificial pancreas

KW - Closed-loop

KW - Continuous glucose monitor

UR - http://www.scopus.com/inward/record.url?scp=85089466946&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85089466946&partnerID=8YFLogxK

U2 - 10.1089/dia.2019.0469

DO - 10.1089/dia.2019.0469

M3 - Review article

C2 - 32069100

AN - SCOPUS:85089466946

SN - 1520-9156

VL - 22

SP - 485

EP - 491

JO - Diabetes Technology and Therapeutics

JF - Diabetes Technology and Therapeutics

IS - 7

ER -

Where Do We Stand with Closed-Loop Systems and Their Challenges

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this